The PhoP virulence regulon and live oral Salmonella vaccines

Vaccine

Volumn 11, Issue 2, 1993, Pages 122-125

  Miller, Samuel I ^a   Loomis, Wendy P ^a   Alpuche Aranda, Celia ^a   Behlau, Irmgard ^a   Hohmann, Elizabeth ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

gene regulation; live oral vaccines; PhoP virulence regulon; Salmonella

Indexed keywords

LIVE VACCINE; SALMONELLOSIS VACCINE;

CONFERENCE PAPER; GENE CONTROL; HUMAN; MUTATION; SALMONELLA TYPHIMURIUM; TYPHOID FEVER; VIRULENCE;

ADMINISTRATION, ORAL; ANIMAL; BACTERIAL PROTEINS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REGULATOR; GENES, STRUCTURAL, BACTERIAL; GENETIC VECTORS; MICE; MUTATION; OPERON; REPRESSOR PROTEINS; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION FACTORS; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; VACCINES, ATTENUATED; VIRULENCE;

EID: 0027397517     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(93)90006-J     Document Type: Article

References (37)

1. Summary of an international workshop on typhoid fever
2. Typhoid fever: pathogenesis and immunologic control
3. Typhoid fever: pathogenesis and immunologic control
4. A seven year field trial of two typhoid vaccines in Guyana
5. A control field trial and laboratory study of five typhoid vaccines in the USSR
6. Evaluation of typhoid vaccines in the laboratory and in a controlled field trial in Poland
7. Controlled field trial in British Guiana schoolchildren of heat-killed phenolized and acetone-killed lyophilized typhoid vaccines
8. Field trials of efficacy of attenuated Salmonella typhi oral vaccine strain Ty21a
9. Salmonella vaccines with mutations in the PhoP virulen regulon
10. Comparative immunogenicity of heat killed and living oral Salmonella vaccines
11. Immunity in experimental salmonellosis
12. Isolation and characterization of gaIE mutant Ty21a of Salmonella typhi: a candidate strain for a live oral typhoid vaccine
13. Inefficacy of the commercial live oral Ty21a vaccine in the prevention of typhoid fever
14. Characterization of the attenuated oral vaccine strain Ty21a
15. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation
16. A gaIE via (Vi) antigen-negative mutant of Salmonella typhi Ty2 retains virulence in humans
17. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
18. A two component regulatory system (PhoP/PhoQ) controls virulence of Salmonella typhimurium
19. Effect of a purA mutation on Salmonella live vaccine vectors
20. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic
21. Role of ompR-dependent genes in Salmonella typhimurium virulence: mutants in both OmpC and OmpF are attenuated in vivo
22. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent
23. Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves
24. Auxotrophic Salmonella typhi as live vaccines
25. Comparison of the safety and immunogenicity of Δ aroc Δ aroD and Δcya Δcrp Salmonella typhi strains in adult volunteers
26. Virulence and vaccine potential of PhoP mutants of Salmonella typhimurium
27. A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells
28. PhoP/PhoQ: macrophage-specific modulators of Salmonella virulence?
29. Salmonella typhimurium phoP virulence gene is a transcriptional regulator
30. Constitutive expression of the PhoP regulon attenuates Salmonella virulence and survival within macrophages
31. A Salmonella typhimurium virulence protein is similar to a Yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein
32. Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes
33. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain
34. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR
35. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector
36. Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon
37. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541 Ty and 543 Ty, as live oral vaccines in humans